ArticleFrontiers in pediatrics2025
Distribution of microsporidia in preterm and full-term infant gut microbiomes and implications for host health.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Confocal microscopy in the early diagnosis of microsporidial keratitis.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Microsporidia are a group of single-celled fungi which infect various chordates including humans, where they mainly pose a risk to immunocompromised individuals. This study aimed to investigate the occurrence of microsporidia in groups of very low birth weight (VLBW) and extremely low birth weight (ELBW) infants, comparing the findings with a publicly available dataset of term infant samples. Methods: Metagenomic sequencing was conducted on stool samples from two cohorts of preterm infants: cohort 1, which included 10 samples collected at 2, 4, and 8 weeks, and cohort 2, which consisted of 12 samples taken at 6 weeks and 2 years. These results were compared with data from a previously published cohort of term infants (cohort 3), which had 19 samples (in duplicates) collected between 1 and 14 weeks. Microsporidia identified from the data were separated and principal component analysis (PCA) was utilized to compare the microbiome of term and preterm infants. Microsporidia species that were significantly different between the two groups were identified using ALDEx2. Results: Early-stage microsporidia distribution did not show significant differences between the cohorts. However, significant differences emerged as the preterm infants grew, particularly at the age of 2 years (cohort 2). The levels of Conclusions: This manuscript reports, to the best of our knowledge, the first occurrence of microsporidia in the early stages of human life. Some microsporidia not only persist into childhood but also become more prevalent during this time. However, we wish to emphasize that the findings from this study should be interpreted with caution, considering the low sample size and comparing cohorts examined at different time points of infants' age. Future studies with larger sample sizes and more mechanistic approaches could help clarify their role in childhood development and long-term health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.